Your browser doesn't support javascript.
loading
The incidence of consecutive manifestations in Von Hippel-Lindau disease.
van der Horst-Schrivers, Anouk N A; Sluiter, Wim J; Kruizinga, Roeliene C; van Leeuwaarde, Rachel S; Giles, Rachel; Olderode-Berends, Maran J W; Links, Thera P.
Afiliação
  • van der Horst-Schrivers ANA; Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Sluiter WJ; Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Kruizinga RC; Department of Geriatric Medicine, Amsterdam UMC, Free University Amsterdam, Amsterdam, The Netherlands.
  • van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Giles R; Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Olderode-Berends MJW; Department of Medical Genetics, University Medical Center Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands.
  • Links TP; Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. t.p.links@umcg.nl.
Fam Cancer ; 18(3): 369-376, 2019 07.
Article em En | MEDLINE | ID: mdl-31087189
ABSTRACT
Von Hippel-Lindau (VHL) disease is an autosomal dominant rare tumor syndrome characterized by high penetrance. VHL mutation carriers develop numerous manifestations in multiple organs during life. The natural course of development of new and growth of existing VHL-related manifestations is still unclear. In this study we aimed to gain insight into the development of subsequent manifestations in VHL disease. We retrospectively scored each new VHL-related manifestation as detected by standard follow-up (retina, central nervous system, kidneys and pancreas, excluding adrenal and endolymfatic sac manifestations) in 75 VHL mutation carriers. The Kaplan-Meier method was used to plot the cumulative proportions of all consecutive manifestations in each organ against age. The cumulative average number of manifestations in all organs during life was calculated by summating these cumulative proportions. Poisson model parameters were used to calculate average time to the detection of consecutive VHL manifestations in each organ. Consecutive VHL-related kidney and retina manifestations during life occur linearly according to Poisson distribution model. The total number of VHL manifestations rises linearly, with an average of seven VHL-related lesions at age 60 years. The incidence of consecutive VHL-related manifestations is constant during life in VHL mutation carriers. Our data is consistent with the notion that somatic inactivation of the remaining allele (Knudson's "two-hit" hypothesis) is the determining factor in developing new VHL-related manifestations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de von Hippel-Lindau Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Fam Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de von Hippel-Lindau Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Fam Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda